| Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review JC Park, SH Han, I Mook-Jung BMB reports 53 (1), 10, 2020 | 156 | 2020 |
| Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease JC Park, SH Han, D Yi, MS Byun, JH Lee, S Jang, K Ko, SY Jeon, YS Lee, ... Brain 142 (3), 771-786, 2019 | 143 | 2019 |
| A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids JC Park, SY Jang, D Lee, J Lee, U Kang, H Chang, HJ Kim, SH Han, ... Nature communications 12 (1), 280, 2021 | 123 | 2021 |
| Aβ1–42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling R Park, SY Kook, JC Park, I Mook-Jung Cell death & disease 5 (6), e1299-e1299, 2014 | 111 | 2014 |
| Annexin A1 restores Aβ1‐42‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway JC Park, SH Baik, SH Han, HJ Cho, H Choi, HJ Kim, H Choi, W Lee, ... Aging Cell 16 (1), 149-161, 2017 | 106 | 2017 |
| Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models H Choi, HJ Kim, J Yang, S Chae, W Lee, S Chung, J Kim, H Choi, H Song, ... Aging cell 19 (1), e13081, 2020 | 95 | 2020 |
| Amyloid β-interacting partners in Alzheimer's disease: from accomplices to possible therapeutic targets SH Han, JC Park, I Mook-Jung Progress in neurobiology 137, 17-38, 2016 | 74 | 2016 |
| Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition JC Park, SH Han, HJ Cho, MS Byun, D Yi, YM Choe, S Kang, ES Jung, ... Alzheimer's Research & Therapy 9, 1-13, 2017 | 59 | 2017 |
| Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer’s disease DK Kim, D Han, J Park, H Choi, JC Park, MY Cha, J Woo, MS Byun, ... Experimental & molecular medicine 51 (11), 1-17, 2019 | 45 | 2019 |
| Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals SH Han, JC Park, MS Byun, D Yi, JH Lee, DY Lee, I Mook-Jung, ... Neurobiology of Aging 73, 21-29, 2019 | 35 | 2019 |
| Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer’s disease JC Park, SH Han, H Lee, H Jeong, MS Byun, J Bae, H Kim, DY Lee, D Yi, ... Progress in Neurobiology 183, 101690, 2019 | 25 | 2019 |
| Low serum phosphorus correlates with cerebral Aβ deposition in cognitively impaired subjects: Results from the KBASE study JC Park, SH Han, MS Byun, D Yi, JH Lee, K Park, DY Lee, I Mook-Jung Frontiers in Aging Neuroscience 9, 362, 2017 | 18 | 2017 |
| Genetic associations of in vivo pathology influence Alzheimer’s disease susceptibility J Seo, MS Byun, D Yi, JH Lee, SY Jeon, SA Shin, YK Kim, KM Kang, ... Alzheimer's research & therapy 12, 1-10, 2020 | 16 | 2020 |
| Association of B cell profile and receptor repertoire with the progression of Alzheimer’s disease JC Park, J Noh, S Jang, KH Kim, H Choi, D Lee, J Kim, J Chung, DY Lee, ... Cell Reports 40 (12), 2022 | 10 | 2022 |
| Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology JC Park, N Barahona‐Torres, SY Jang, KY Mok, HJ Kim, SH Han, KH Cho, ... Advanced Science 9 (23), 2201212, 2022 | 10 | 2022 |
| The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit HJ Kim, JC Park, KS Jung, J Kim, JS Jang, S Kwon, MS Byun, D Yi, ... Experimental & molecular medicine 53 (6), 1046-1054, 2021 | 8 | 2021 |
| Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease JC Park, H Lim, MS Byun, D Yi, G Byeon, G Jung, YK Kim, DY Lee, ... Experimental & Molecular Medicine 55 (5), 1023-1032, 2023 | 7 | 2023 |
| Neurotoxicity of phenylalanine on human iPSC-derived cerebral organoids J Kim, S Lee, J Lee, JC Park, KH Kim, JM Ko, SH Park, SK Kim, ... Molecular Genetics and Metabolism 136 (2), 132-144, 2022 | 7 | 2022 |
| Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition JC Park, KS Jung, J Kim, JS Jang, S Kwon, MS Byun, D Yi, G Byeon, ... Alzheimer's Research & Therapy 13, 1-10, 2021 | 7 | 2021 |
| Application of QPLEXTM biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition D Lee, JC Park, KS Jung, J Kim, JS Jang, S Kwon, MS Byun, D Yi, ... Experimental & molecular medicine 54 (1), 61-71, 2022 | 2 | 2022 |
